GlassScriptPhysician profile
George A Johnson
NPI 1326145590
$2,016.37
in general payments reported to CMS, 2019-2025
40 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $367 · 2021: $726 · 2022: $102 · 2023: $23.27 · 2024: $93.94 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $313.26 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $242.25 | 2019-2025 | |
| Janssen Biotech, INC. | $120.09 | 2019-2025 | Erleada |
| Endo Pharmaceuticals INC. | $104.55 | 2019-2021 | |
| Boston Scientific Corporation | $93.65 | 2019-2020 | |
| Abbvie INC. | $74.67 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $73.07 | 2022 | |
| Axonics, INC. | $68.71 | 2021-2024 | Axonics |
| Travere Therapeutics, INC. | $67.49 | 2020-2021 | |
| Hollister Incorporated | $61.31 | 2020-2021 | |
| Amgen INC. | $56.23 | 2020-2021 | |
| Myovant Sciences INC. | $51.53 | 2021 | |
| Merck Sharp & Dohme LLC | $44.97 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $44.70 | 2020-2021 | |
| Antares Pharma, INC. | $44.65 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $41.79 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $38.97 | 2021 | |
| Medtronic USA, INC. | $37.59 | 2019-2020 | |
| 180 Medical, INC. | $32.75 | 2021 | |
| Allergan, INC. | $30.37 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $29.43 | 2020 | |
| Pfizer INC. | $27.80 | 2020-2021 | |
| Coloplast Corp | $26.83 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $25.94 | 2025 | |
| Sagent Pharmaceuticals | $25.18 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.71 | 2021 | |
| Abc Home Medical Supply, INC. | $21.27 | 2025 | |
| Dentsply Ih INC. | $19.12 | 2021 | |
| Verity Pharmaceuticals INC. | $17.94 | 2021 | |
| Mission Pharmacal Company | $17.24 | 2020 | |
| Metuchen Pharmaceuticals | $16.79 | 2019 | |
| Urogen Pharma, INC. | $15.95 | 2024 | |
| Sumitomo Pharma America, INC. | $15.91 | 2024 | Orgovyx |
| Urovant Sciences INC | $14.84 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $14.47 | 2019 | |
| Dendreon Pharmaceuticals LLC | $13.98 | 2020 | |
| Rochester Medical Corporation | $12.89 | 2019 | |
| Blue Earth Diagnostics | $12.28 | 2021 | |
| Aytu Biopharma, INC. | $11.96 | 2020 | |
| Photocure INC | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.